MedPath

Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure

Recruiting
Conditions
Emergencies
Acute Heart Failure
Registration Number
NCT05871138
Lead Sponsor
University of Monastir
Brief Summary

prognostic value of delta LUS score of patients hospitalized for acute heart failure within 30 days of discharge.

Detailed Description

The aim of our study is to evaluate the contribution of the variation of the LUS score performed at the time of admission (LUS1) and at discharge (LUS2) in predicting the clinical course of patients admitted for acute cardiac decompensation 30 days after discharge.

Delta LUS score=((LUS2-LUS1) \*100)/LUS1

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Patients aged over 18 years,
  • Patients hospitalized in the emergency department for dyspnea having as etiology an acute heart failure and in whom will be performed two pulmonary ultrasound examinations (at entry and exit).
Exclusion Criteria
  • Age less than 18 years
  • Dyspnea of non-cardiac etiology (cause: pulmonary, traumatic, toxic...)
  • Altered state of consciousness (Glasgow score<14)
  • Hemodynamic instability: presence of peripheral signs of shock, use of vasoactive drugs
  • Mechanical ventilation from the outset
  • Cardiorespiratory arrest
  • Inability to give consent to the study
  • Missing one of two ultrasound examinations
  • Unable to make telephone contact after one month.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Delta lus30 days

The primary outcome evaluate the contribution of the variation of the LUS score performed at the time of admission (LUS1) and at discharge (LUS2) in predicting the clinical course of patients admitted for acute cardiac

Readmission30 days

Readmission

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Semir Nouira

🇹🇳

Monastir, Monastur, Tunisia

Emergency Departement

🇹🇳

Monastir, Tunisia

© Copyright 2025. All Rights Reserved by MedPath